Selected Start-Ups (12/00)
In Vivo summarizes the technologies of several recently founded companies: Roche has funneled its IP in antibiotics, antifungals and dermatology into spin-off Basilea Pharmaceutica. Building on technology invented by NASA to detect life on Mars, BioLuminate Inc. will develop a diagnostic probe to measure breast cancer indicators after initial screening has revealed a region of concern. Integrative Proteomics Inc. aims to be a dominant player in proteomics with its platform for high-throughput protein expression and purification, protein-protein interaction and 3-dimensional structure determination. invivodata inc. is offering a money-back guarantee to users of its invivosystem, a handheld method for recording, managing and analyzing real-time patient experience data during pharmaceutical clinical trials. Metazoa Systems Inc. has launched a web portal offering research management tools for life science researchers. Aventis CropScience spin-off Scynexis Chemistry & Automation Inc. will provide drug discovery chemistry services for pharmaceutical and other life sciences clients.
You may also be interested in...
First quarter submission volume is the second lowest of the GDUFA era, in part because of BE study problems caused by the pandemic.
The Centers for Medicare and Medicaid Services has agreed to provide national Medicare coverage for mitral valve transcatheter edge-to-edge repair under a new coverage with evidence development policy. See what Neil Moat, chief medical officer for Abbott’s structural heart business, said about it here.
South Korea’s Ministry of Food and Drug Safety and Taiwan’s Food and Drug Administration will transition from ICCR observers to full members, joining regulatory authorities from the US, Europe, Japan, Canada and Brazil. PCPC’s Francine Lamoriello, EVP of global affairs, discusses.